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Abstract
The M2 protein of influenza A viruses forms a tetrameric pH-activated proton-selective channel that
is targeted by the amantadine class of anti-viral drugs. Its ion channel function has been extensively
studied by electrophysiology and mutagenesis; however, the molecular mechanism of proton
transport is still elusive, and the mechanism of inhibition by amantadine is controversial. We review
the functional data on proton channel activity, molecular dynamics simulations of the proton
conduction mechanism, and high-resolution structural and dynamical information of this membrane
protein in lipid bilayers and lipid-mimetic detergents. These studies indicate that elucidation of the
structural basis of M2 channel activity and inhibition requires thorough examination of the complex
dynamics of the protein and the resulting conformational plasticity in different lipid bilayers and
lipid-mimetic environments.
A. Function of the M2 proton channel of influenza A viruses
The M2 protein of influenza A and B viruses forms tetrameric proton channels that are
important for the viral life cycle. After the virus enters the infected cell by endocytosis, the M2
proton channel opens in response to the low pH of the endosome, allowing proton flux into the
virus, which triggers the dissociation of the viral RNA from the matrix proteins and the fusion
of the viral and endosomal membranes. These events release the viral RNA to the cytoplasm
for replication by the host cell (1). In a later stage of virus replication, the M2 protein maintains
the high pH of the trans-Golgi network and prevents premature conformational changes of
hemagglutinin in viruses with a high pH optimum of hemagglutinin-induced fusion (2).
The influenza A M2 (AM2) protein contains a short N-terminal periplasmic domain, a
transmembrane (TM) domain, and a C-terminal cytoplasmic tail (Fig. 1). It is one of the
smallest ion channel proteins and thus an excellent system for elucidating the structure-function
relation of ion channels. Extensive mutagenesis, electrophysiology (3,4) and sedimentation
equilibrium experiments (5) have been conducted to characterize the function and stability of
AM2 (for recent reviews, see (6,7)). The AM2 proton channel is also the target of the
amantadine class of drugs, one of only two classes of anti-influenza drugs currently available.
However, the efficacy of amantadine dropped by two orders of magnitude between 2002 and
2007, although the 2008 seasonal flu strains were largely sensitive to amantadine. The
resistance mainly resulted from the S31N mutation in the M2 TM domain (8). Thus, elucidating
the mechanism of amantadine inhibition of AM2 has great public health relevance.
Recently, several high-resolution structural studies have been carried out to determine the
structural basis of AM2 proton conductance and inhibition. In this article, we summarize the
main functional data of AM2 and high-resolution structural information available on the TM
domain, to promote future investigations of this intriguing and far from understood membrane
protein.
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Proton transport, selectivity, and activation
The proton conductance of AM2 has been well studied both in vivo and in vitro since its
discovery as an ion channel (3). The gold standard of M2 functional assays is the replication
of live viruses in infected cells, followed by the “silver standard” of whole-cell conductance
data in Xenopus laevis oocytes. The wild-type protein is activated below pH 6.2 and its current
is sensitive to amantadine. The single-channel activity under a −130 mV voltage is ~0.16 µA/
ng protein at pH 6.2 for the A/Udorn/72 strain of M2 (4), which corresponds to 12 aA per
channel, a conductance of ~100 aS, or ~100 protons per second. Extraction of single-channel
currents requires quantification of the amount of protein, and the assumption that all proteins
form open channels or the knowledge of the fraction of open channels.
For in-vitro liposome assays, several additional factors such as the orientation of the protein
in the membrane, the size and buffering capacity of the liposomes, and the fluxes of other
monovalent ions (Na+ and K+) can affect the measured conductance. One of the most reliable
liposome assays employed an intravesicular pH-sensitive dye to measure proton fluxes, and
obtained a single-channel current of 2.7 aA at pH 5.7 and 18°C (conductance = 29 aS) for full-
length M2 in DMPC/DMPS vesicles (9). These values agree well with the oocyte result (4).
Several other liposome assays gave more divergent values due to different experimental
designs and protein constructs (10–12). However, the general consensus is that the single-
channel conductance of M2 ranges from tens of aS to a few hundred aS, indicating low transport
rates of ten to several hundred protons per second at mildly acidic pH. It is thought that the
low currents are a result of the low physiological proton concentration (9), although the idea
that M2 may have some characteristics of transporters has also been proposed (13).
There is general consensus that AM2 is selective for protons over Na+ and K+ by a factor of
1.5–3.0 × 106 (9,14,15), and that the increased proton current at low exterior pH (pHout) is due
to true activation of the channel rather than mere mass action, since increased pHout stops the
outward current of acidified cells (15,16). The site of activation is His37, the only residue in
the TM domain that can be protonated within the relevant pH range. Mutation of His37 to either
Gly or Glu results in channels that are no longer modulated by pHout (17). Solid-state NMR
(SSNMR) studies of His37 in the TM peptide M2(22–46) suggest that it is the third protonation
at pH 6.3 that opens the channel (18).
His37 selectivity filter and Trp41 gate in the TM domain
His37 and Trp41 are the two most conserved residues in the M2 protein of influenza A strains
(19) and are essential for channel function. His37 protonation is responsible for the activation
and selectivity of the channel. The wild-type (WT) A/Udorn/72 M2 protein has 50-fold
conductance difference between pHout of 4.5 and 8.2. In contrast, many His37 mutants, while
still forming channels, are toxic to oocytes and have pH-independent currents, indicating non-
specific conductance of other cations (17). These mutants can be neither activated effectively
by low pHout (H37G, H37S and H37T) (20) nor inactivated by high pHout (H37G, H37E and
H37A) (17). The mutant channels are not proton selective and are only partially and reversibly
blocked by amantadine (20), in contrast to the WT protein (16). Although the H37 mutants are
still tetrameric in oocytes (20), analytical ultracentrifugation (AUC) experiments indicate that
H37A and H37F mutants are 3.1 and 1.8 kcal/mol less stable than the WT peptide in DPC
micelles (21).
When a high concentration of imidazole buffer is added to the bathing solution, proton-selective
conductance and gating are partially restored to the His37 mutants (20). This chemical rescue
is specific to imidazole and does not require interaction with Trp41. Thus, His37 was proposed
to be an intermediate proton acceptor and donor, consistent with SSNMR titration data of the
TM peptide (18).
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The M2 proton channel responds exclusively to external pH: low pHout activates the channel
and high pHout closes the channel, regardless of the interior pH. Mutagenesis data indicates
that Trp41 acts as the gate in concert with His37 (22). At high pHout and low pHin, the WT
protein does not exhibit outward current while W41A/C/F mutants do, indicating loss of gating
by the mutants (22). Further, intracellular Cu2+ inhibited the open W41A channel but not the
WT channel, indicating that Trp41 shields His37 from coordination by Cu2+ (22,23). These data
suggest that the indole rings adopt distinct conformations at different pHout to obstruct or open
the pore. Resonance Raman data indicate that the Trp41 conformational change must be small
to keep its environmental hydrophobicity unchanged (24). Concerted conformational changes
seem necessary for His37 to act as the selectivity filter and Trp41 as the gate. Compared to
His37, the two Trp41 mutants that abolish gating (W41A and W41F) (22) actually have
enhanced tetramer stability in DPC micelles (21), indicating that this residue has evolved for
function rather than stability.
Mechanism of proton transport
Molecular dynamics (MD) simulations have been used extensively to study the M2 proton
transport mechanism. The basic premise is that protons hop along a water wire via the Grotthuss
mechanism, but the water wire is broken at the narrow His37 constriction (and possibly other
locations along the channel). Thus, the mechanism of proton passage through the His37 tetrad
is the central question. Two main models have been proposed: the gating model and the shuttle
model. In the gating model, protonation of the His37 tetrad at low pH causes pore opening by
electrostatic repulsion, so that a continuous water wire is formed (25). Conformational changes
of the His37 and possibly Trp41 are necessary in this model. MD simulations suggest that a 60°
change of the His37 χ2 angle may be sufficient to open the pore (26), and the excess proton
may form a Zundel complex with two water molecules on the extra- and intracellular side of
the histidine rings (27,28). Early MD simulations postulated various charged states of His37
for channel activation (29). However, with SSNMR data indicating the third protonation of the
His37 tetrad to be responsible for channel opening (18), recent simulations confirmed that the
+3 state has the lowest proton permeation free energy (30). The channel water molecules that
transport the protons were calculated to have three-fold lower diffusion coefficients than bulk
water (27,31).
The second proton transport model is the shuttle model, where the imidazole nitrogen facing
the extracellular side binds one proton to form a biprotonated intermediate, then the other
nitrogen releases the proton on the intracellular side and returns the imidazole to the neutral
form (32). The initial state is then recovered by tautomerization or ring flip of the imidazole.
This model explains the low proton transport rate and low-pH saturation of the channel, since
both would be associated with the limiting rate of His37 sidechain torsional motion or
tautomerization.
Simulations of the protein conformation at different pH also shed light on the mechanism of
proton transport. One proposal is that in addition to His37, Val27 may act as a secondary gate
that breaks the water wire, especially in the presence of amantadine (33). The two gates may
not be static but instead may move synchronously in response to His37 protonation: at high pH
the Val27 region opens while the His/Trp region narrows, and the opposite is found at low pH
(13). Thus, instead of equating high pH with the closed state and vice versa, these simulations
suggest a more complex view of an Openout-Closedin conformation at high pH and Closedout-
Openin conformation at low pH. This model reconciles the different helix orientations and
packing in different high-resolution structures (34–37).
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Inhibition of the AM2 channel
Three classes of M2 inhibitors have been identified so far: the adamantane analogs (38,39),
the spirene-containing compounds (40), and Cu2+ ions. The FDA approved amantadine
achieves its antiviral effect by inhibiting the M2 proton channel activity (3): 100 µM
amantadine nearly irreversibly blocks > 90% of the channel activity of A/Udorn/72 (H3N2)
M2 in several minutes at both acidic and neutral pH (16,41,42). For some other influenza strains
the amantadine block is moderately stronger (50% - 2 fold) at neutral pH than at low pH (16).
The Hill coefficient of the amantadine block is 1, consistent with the scenario that a single drug
inhibits each functional channel (16).
Naturally occurring mutations in the TM domain that confer amantadine resistance include
L26, V27, A30, S31, and G34, all N-terminal to G34 (8,38,43,44) (Fig. 1). Extensive whole-
cell conductance studies have been carried out on these mutants. S31N, the most common
resistant mutant (8), has an IC50 of 199.9 µM, more than ten times higher than that of the WT
(IC50 = 16 µM) (41). The resistance is not due to altered channel activity, as S31N has very
similar specific activity and acid activation as the WT (4,42). L26F has ~35% higher channel
activity than S31N but is more sensitive to amantadine (42). G34E has a 3-fold higher specific
activity than S31N and is about 5-fold less sensitive to amantadine than S31N (4). V27 mutants
have mixed phenotypes: V27A and V27S are amantadine resistant but V27T is amantadine
sensitive, and all V27 mutants have significantly increased (~ 3 fold) channel activities than
WT (4). In contrast, the A30T mutant has a greatly reduced but still detectable activity, while
the A30P mutant is inactive (4). Thus, residue 30 appears to be important for maintaining a
functional structure of the protein. Among the resistant mutants, S31N was found by thiol-
disulfide exchange experiments to be stable in both bilayers and micelles (42), suggesting a
reason for its dominance in current flu strains that is independent of the selective pressure of
amantadine. The stability and similar channel activity of S31N to the WT protein argue against
the model that the S31N variant is resistant to amantadine by destabilizing the closed state and
favoring the open state of the channel (45). The latter hypothesis was made based on the larger
NMR linewidths of S31N than WT proteins in the presence of rimantadine. However, since
S31N does not bind rimantadine, the more relevant comparison should be between S31N and
the apo WT protein, which is known to exhibit broad linewidths as well.
In the C-terminal region of the TM domain, L38F, W41A, and D44A mutants incorporated
into influenza viruses showed similar growth as the WT protein in infected cells, and the growth
is sensitive to amantadine (41) (despite the fact that the W41A mutant does not gate properly
(22)). Electric recordings in oocytes indicate that the IC50 of D44A is 15.8 µM,
indistinguishable from the WT protein. Thus, no amantadine-resistant mutations have been
found C-terminal to G34, implicating the segment between L26 and G34 to be the amantadine-
binding region (41). Further, when residues 6–18 of the amantadine-insensitive BM2 were
replaced by AM2 residues 24–36, the chimeric protein showed amantadine-sensitive currents
in oocytes (41), indicating that the C-terminus is not the pharmacologically relevant region
associated with amantadine's antiviral effect. In contrast, a recent liposome proton flux assay
of M2(18–60) found the D44A mutant to be resistant to rimantadine while the S31A mutant
to be sensitive, supporting a C-terminal binding model (34,45). This liposome assay data is in
serious contradiction both with the chimeric protein result and with the finding from the “gold
standard” assay that replication of live virus bearing the D44A mutation is inhibited by
rimantadine (41).
The second class of M2 inhibitors are spirene-containing compounds, initially discovered from
a growth impairment assay where the M2 toxicity to yeast cells due to its proton channel activity
is reversed by inhibitors (40). The first compound, BL-1743 (2-[3-azaspiro(5,5)undecanol]-2-
imidazoline), has similar inhibition rate, Hill coefficient, and spectra of resistance as
amantadine (46). However, BL-1743 inhibition is reversible (~12 minutes) while amantadine
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block is irreversible on the experimental time scale (~30 minutes). BL-1743 also differs from
amantadine in its interaction with I35: the I35T mutant is resistant to BL-1743 but is reversibly
inhibited by amantadine (46). The cause of this difference is suggested by a recent SSNMR
study of the analogous spirene-piperidine compound, 3-azaspiro (5,5) undecane hydrochloride
(IC50 = 0.92 µM) (47). This compound reduces the dynamic disorder of the G34-I35 backbone
of AM2, suggesting that spirene-amine inhibitors bind more extensively and strongly with the
TM helices than the adamantane inhibitors.
B. High-resolution structure of AM2 TM domain
Orientation of the TM helices in lipid bilayers
The TM peptide of AM2 has been a prime target for high-resolution structure investigation by
a number of biophysical techniques. Both global structural information such as helix
orientation and site-specific information of key residues have been obtained. The orientation
of the TM helices in lipid bilayers has been extensively studied by SSNMR, EPR and IR
techniques. The majority of SSNMR studies measured orientation-dependent 15N tensors on
glass-plate aligned M2(22–46) (37,48–51) and to a small extent on aligned full-length M2
(52,53). From 1D 15N chemical shift anisotropies (CSA), Cross and coworkers obtained a helix
tilt angle of 33°–37° for M2(22–46) in DMPC bilayers (49,50) and 33° in DOPC bilayers. 2D
NMR spectra correlating 15N-1H dipolar couplings and 15N CSAs gave more precise
orientational constraints, including both the tilt angle (τ) and the rotation angles (ρ) of
individual residues. From these 2D spectra, the tilt angle of apo M2(22–46) in DMPC bilayers
was refined to 38° (51), while the rotation angles around the helix axis are consistent with the
pore- or lipid-facing positions of residues inferred from functional data (PDB: 1NYJ).
Prior to 2001, the oriented NMR studies were conducted on peptides that were first mixed with
lipids in organic solvents before hydration. These samples were not pH controlled and may be
acidic due to the TFA salt associated with the peptide. After 2001, the oriented membranes
were prepared by an aqueous protocol where M2 was reconstituted into lipid bilayers by
detergent dialysis at controlled pH before alignment on glass plates. The amantadine-bound
M2(22–46) and the full-length M2 were studied in this way. In DMPC/DMPG lipid bilayers,
the 2D spectra of uniformly 15N-labeled full-length M2 at pH 8.0 showed a TM helix with a
25° tilt, which is smaller than the tilt of the TM peptide alone, and an 80° tilted helix, which
is attributed to an amphipathic helix C-terminal to the TM domain (52). Hydrogen/deuterium
exchange of full-length M2 showed that the TM helix underwent fast H/D exchange, consistent
with its participation in forming an aqueous pore, while the 80°-tilted helix resisted H/D
exchange, suggesting that it is shielded from water. Full resonance assignment is necessary to
elucidate the orientation and depth of this C-terminal amphipathic helix.
Upon amantadine binding, M2(22–46) exhibits a pronounced kink at G34 in DMPC bilayers,
with a tilt angle of 31° for the N-terminal segment and 20° for the C-terminal segment (PDB:
2H95) (Fig. 5a) (48). While it is tempting to conclude that amantadine caused this kink, the
bound peptide spectra were obtained from aqueous prepared samples at pH 8.8, under which
condition there is no comparable apo peptide data. It is thus possible that the kink may already
be present in the apo state, especially given the known propensity of Gly to perturb α-helices.
Indeed, other high-resolution structures of AM2 suggest a G34 kink already in the apo state.
For example, MAS-NMR data of DLPC-bound M2 suggest a kink of 5° for the bound peptide
and 8° for the apo peptide (36), while the crystal structure of apo M2 at neutral pH shows a
distribution of helix kink angles (35).
Direct comparison of the orientation of amantadine-free and amantadine-bound M2(22–46)
prepared under the same conditions was reported recently (54). Using unoriented DLPC
vesicles and dialysis reconstituted M2(22–46), Hong and coworkers determined the helix
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orientations by exploiting the uniaxial diffusion of the helical bundles around the bilayer
normal. The N-terminal half of the TM segment was found to have a tilt angle of 35° in the
apo state and a slightly larger tilt of 38° in the amantadine-bound state (55) (Fig. 5d), indicating
that the drug slightly enlarges the pore vestibule.
The TM helix orientation is also sensitive to membrane thickness. EPR spectra of N-terminus
nitroxide labeled M2(22–46) reconstituted into DLPC, DMPC, DOPC, and POPC bilayers
showed the least dipolar broadening in the thinnest DLPC membrane and the strongest
broadening in the thickest POPC membrane (56). The broadening is attributed to shorter
interhelical distances as the peptide decreases its tilt angle in the thicker membrane. The
orientational change was detected directly in SSNMR spectra of unoriented M2(22–46). The
TM helices showed a tilt angle of 35° in DLPC bilayers but a much smaller angle of 26° in the
thicker POPC bilayers (54). These results are consistent with AM2 adjusting its TM helix
orientation to minimize the hydrophobic mismatch with the lipid bilayer, as also observed for
other membrane peptides (57,58). These results revise an earlier conclusion that the M2 helix
orientation is intrinsic to the peptide and unaffected by the membrane (50), made based on the
fortuitously similar orientations of the peptide in DMPC and DOPC bilayers because of the
similar thickness of these two bilayers.
The SSNMR and EPR orientational studies do not detect evidence of rotational angle change
of M2 by pH: both the organic-solvent prepared samples, which likely have acidic pH, and the
aqueous samples at high pH, gave the same rotation angles. These results are consistent with
the functional requirement for a hydrophilic pore. Distances between the Trp41 indole 5-19F
of neighboring helices were also found to be the same (11.8 Å) at pH 7.5 and pH 4.5 (Fig. 2),
consistent with the lack of ρ change (59). Thus, it is surprising that a recent IR study of M2
(22–46) in DMPC bilayers reported a one-residue (100°) rotation of the helices between low
and high pH (60). The ρ angle of the low pH samples was found to agree well with early
SSNMR data (37,51) while that of the high pH samples differ by ~100°. When the ρ angles
were combined with the +3 protonated His37 tetrad, MD simulations found that the rotated
helices reduce His37 exposure to water at high pH, thus rationalizing channel closure (61). The
ρ angles were extracted from diagonal linewidths of 2D IR spectra, which reflect the
electrostatic environment of the 13C=18O groups, the main contributor of which is thought to
be the water contact. However, the 2D lineshape analysis requires the distinction of
homogeneous and inhomogeneous linewidths, consideration of population relaxation times,
and consideration of water-independent electrostatic effects such as hydrogen bond network
of the peptide. Thus the origin of the diagonal linewidth change is complex. In addition, linear
FT-IR dichroism data for the high pH samples reported in this work do not show a clear
sinusoidal dependence with the residue number, casting further doubt on the high pH ρ angle
result (60).
Tetramer stability and packing
In mammalian cells and oocytes the functional state of M2 is tetrameric, as shown by sucrose
gradient, chemical cross-linking (62) and conductance experiments (5). In detergents and lipid
bilayers, the TM peptide retains the tetrameric state under a wide range of conditions, and the
monomer-tetramer equilibrium is readily shifted by membrane thickness, pH, amantadine
binding, cholesterol, and amino acid sequence. The environmental effects on the free energy
of tetramer association have been the focus of study using AUC in micelles (21,63) and thiol
disulfide exchange in lipid vesicles (64). It was shown that M2(19–46) tetramers are
increasingly stabilized in the direction of detergents ≪ DLPC < DMPC < POPC. Among lipid
bilayers the hydrophobic-thickness matched bilayers produce the most stable tetramers (64),
but even the thinnest bilayer (DLPC) induces 100-fold tighter tetramer association than
detergents. Both amantadine and cholesterol shift the equilibrium to tetramers (64,65).
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Compared to external environmental factors, the sequence requirement for tetramer formation
is much more lenient: Ala and Phe mutations of a number of pore residues retain stable M2
(22–46) tetramers in DPC micelles, with the exception of the functionally essential His37
(21). However, more stable tetramers are often less functional tetramers, as manifested by their
reduced ability to bind amantadine (63). For example, the most amantadine-resistant S31N
mutant forms 0.4 kcal/mol more stable tetramers than the WT protein (42). This inverse
relationship between stability and function suggests that the multiple M2 functions –proton
conduction, gating and inhibitor binding – may require conformational flexibility, which
cannot be provided by highly stable mutants locked in the wrong conformational minima.
Direct distance constraints for M2 tetramers in lipid bilayers were recently reported based
on 19F spin diffusion SSNMR experiments that probe 19F-19F distances in the ~10 Å range
(66,67). So far, four interhelical 19F-19F distances have been reported for M2(22–46) in DMPC
bilayers. On 4-19F labeled A30F M2, the 19F spin diffusion equilibrium value of 1/4 directly
proved the tetrameric state, and the decay trajectory yielded a distance of 8.5 ± 0.6 Å between
nearest neighbor helices (Fig. 2a). This distance rules out helix tilt angles smaller than 20° and
constrains the Phe χ1 angle. The 19F NMR data of V27F suggest incomplete tetramer formation
(partial dimers), which is consistent with the reduced stability of this mutant seen in AUC
experiments (21). The L38F NMR data also indicated distance heterogeneities (59).
His37 and Trp41 sidechain conformation
A semi-quantitative 13C-15N distance between His37 Nπ and Trp41 Cγ was measured on
DMPC-bound M2(22–46) at pH 7 and 38°C using SSNMR REDOR experiments (37).
Significant dipolar dephasing was observed that corresponded to a minimal coupling of 63±12
Hz (37) or a maximum distance of 3.9 Å. The limiting nature of this result is because the
measurements were done at physiological temperature where M2(22–46) undergoes uniaxial
diffusion around the bilayer normal, which averages the dipolar coupling (50,54). Scanning
the possible His and Trp rotameric states indicate that this C–N distance must be between
helices i and i+1, and suggested that His37 adopts the t-160 (χ1=180°, χ2=−160°) rotamer while
Trp41 adopts the t-105 rotamer (PDB code: 1NYJ) (37). Subsequent reexamination of the
conformational space of the two residues indicates that other possible solutions also exist:
His37 can adopt the t-160 or the t60 rotamer, while Trp41 can adopt the t-105 or the t90 rotamer.
Density functional theory calculations and MD simulations suggest that the most stable
combination is (t60, t90) (26).
19F spin diffusion NMR experiments provided a direct distance constraint on the Trp41
sidechain conformation. The i - i+1 distance between 5-19F-Trp41 of M2(22–46) was measured
to be mainly 11.8 Å at pH 7.5 (59) (Fig. 2a), and the value does not change significantly with
amantadine binding and pH. When the helix orientation is fixed to 35° and the channel diameter
is fixed to 10.2 Å between G34 Cα, the only Trp41 rotamer that is consistent with the 19F-19F
distance is t90, which is consistent with the MD prediction (26). Combined with the measured
His37-Trp41 C–N distance, the (t-160, t90) rotamer pair was proposed for the closed state of
His37 and Trp41 (59). This conformation suggests that it may not be Trp41 alone but rather the
cation-π interaction between His37 and Trp41 that is responsible for gating and the shielding
of His37 from intracellular ions (Fig. 2b).
A third Trp41 rotamer of (χ1=−100°, χ2=+100) was proposed for the high pH state of M2 based
on analysis of 19F NMR lineshapes under the combined effects of 19F CSA and 19F-19F
interhelical dipolar couplings (68). However, the presence of intermediate time scale
broadening of the spectra and the lack of information on the orientational angles between
the 19F chemical shift tensor and the F-F dipolar tensors make this analysis a severely under-
determined problem. The resulting rotamers are also inconsistent with any of the computational
predictions (26).
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His37 protonation state
The charged state of His37 gives crucial information on the activation of the M2 proton channel.
The pKa of His37 in micelle-bound M2(22–46) was measured by 1H solution NMR to be 6.8
for the monomer and 6.4 for the tetramer in the absence of drug (65). Amantadine decreases
the tetramer pKa to 5.8. UV resonance Raman experiments on M2(22–46) in POPE/POPS
membranes found a pKa of 5.7 based on the intensity of the 1407 cm−1 band (24). This
imidazole band has the same intensity in liposomes and in SDS micelles at pH 4.0, indicating
that all four His residues are protonated at pH 4.0 (24).
By far the most definitive study of His37 protonation states came from 15N SSNMR
experiments of M2(22–46) in DMPC/DMPG bilayers by Cross and coworkers (18), who
monitored the imidazole Nδ1 and Nε2 15N isotropic chemical shifts as a function of pH. Two
neutral tautomers were found at pH 8.6, with the unprotonated nitrogen exhibiting a large
isotropic shift of ~230 ppm. Between pH 8.0 and pH 7.0, two +1 dimer species, His-HisH+,
were concluded. Based on the relatively large 15N linewidths in this pH range, which suggest
intermediate time scale motion, low-barrier hydrogen bonds between imidazole and
imidazolium within each dimer were proposed. Below pH 6.5 and pH 5.0, the third and fourth
His are protonated. Quantification of the spectral intensities yielded four pKa’s at 8.2, 8.2, 6.3
and < 5.0. Thus, the first two histidines titrate cooperatively at higher pH than the aqueous
pKa of His (6.0). Since the +1 dimers already exist at neutral pH, they are proposed to form a
histidine-locked state that occludes the pore (18). The binding of the third proton below pH
6.3 was proposed to break the two-fold symmetry of the +1 dimers and thus activates the
channel.
Amantadine binding changes the titration curve of the His37 tetrad (69). The 230 ppm
unprotonated 15N peak persisted to a much lower pH of 6.0 in the presence of the drug. Intensity
analysis shows that the bound peptide has only one pKa near 5.4. The nature of this apparently
highly cooperative protonation event is still unknown. In addition, the 15N peak associated
with the His-HisH+ dimer is no longer observed in the amantadine-bound peptide, suggesting
that the neutral tautomers directly form biprotonated histidines in the presence of amantadine.
Further studies are necessary to elucidate the amantadine-induced changes of His37
protonation.
Extensive conformational dynamics of AM2
The M2 homo-tetramer exhibits extensive conformational dynamics in lipid bilayers and lipid-
mimetic detergents, as well documented by SSNMR and solution NMR spectra. Membrane-
bound apo M2(22–46) shows dynamically broadened lines in both unoriented vesicle spectra
(36,55) and oriented spectra (70) at ambient temperature in a range of model membranes:
DLPC, DMPC/DMPG, and POPC. The fact that the line broadening is mainly dynamic in
origin rather than due to static conformational distributions is proved by the temperature
dependence of the linewidths. The broadest lines are observed between 298 K and 263 K
(54), above and below which the lines narrow (Fig. 3a). Acidic pH broadens the lines compared
to neutral pH for both membrane-bound M2(22–46) (70) and detergent-bound M2(18–60)
(34). In all solvent environments and for both M2(22–46) and M2(18–60), amantadine
noticeably narrows the linewidths (Fig. 3b). The line broadening or narrowing occur for all
residues, thus it reflects the dynamic property of the whole protein rather than segmental
motion.
The origin of the broad linewidths and their narrowing by amantadine has been examined in
detail by SSNMR (54,71). The main motion accounting for the broad linewidth is the whole-
body uniaxial diffusion of the tetramers around the bilayer normal, as shown by motionally
averaged 2H, 15N and 13C NMR lineshapes (Fig. 4a, b) (54). The correlation time of this
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uniaxial diffusion has been estimated from relaxation studies to be ~3 µs (71) for DLPC-bound
apo M2(22–46) at 313 K, which is very close to the time scale of the radio-frequency pulses
and nuclear spin interactions (2–4 µs), thus causing intermediate time scale broadening.
Amantadine binding reduces the correlation time by 2–3 fold at 313 K (71) (Fig. 4c), thus
avoiding exchange broadening and narrowing the NMR lines. The larger diffusion rates
strongly suggest that amantadine promotes the formation of more homogeneous helical bundles
(Fig. 4d), which is consistent with the increased tetramer stability observed in thiol disulfide
exchange experiments (64). The NMR relaxation data also indicate that excess amantadine in
the bilayer increases the membrane viscosity. Since protein rotational diffusion is generally
sensitive to membrane viscosity, cholesterol-rich virus-mimetic membranes immobilize this
diffusion, and was found to suppress exchange broadening and give rise to high-resolution
NMR spectra in a wide temperature range (72).
Whether the whole-body uniaxial diffusion has functional importance is not known. If the viral
envelope is in a liquid-ordered phase, then M2 is most likely immobilized. But if the virus
envelope contains significant liquid-disordered domains, then the fact that M2 is poorly
incorporated into raftlike microdomains (73) should promote uniaxial diffusion in the
functional state. Most spectroscopic studies so far were carried out on M2 bound to non-
cholesterol-containing membranes or bound to detergents, which favor the whole-body motion.
Thus site-specific conformational dynamics have not been separated from the whole-body
motion. In this light, the larger linewidths of M2 at low pH are at least partly due to global
motional changes, and their interpretation in the context of pH activation needs to be considered
carefully (34,70).
Amantadine binding in high-resolution structures
Two atomic-resolution structures of TM-containing portions of AM2 were recently solved
using X-ray crystallography and solution NMR, which shed light on the pH activation of the
channel and led to two different models of M2 inhibition (74).
The crystal structures were solved on M2(22–46) in octyl-β-D-glucopyranoside (OG) at pH
7.3 in the absence of amantadine (PDB: 2BKD) (2.0 Å resolution) and at pH 5.3 in the presence
of amantadine (PDB: 3C9J) (3.5 Å resolution) (35). In both structures, the N-terminal half of
the TM domain has a tilt angle of ~35°, consistent with SSNMR data (51,54). The orientation
of the C-terminus half of the TM helix depends on the pH: at low pH the helices are uniformly
straight and diverge toward the C-terminus, creating an open cavity, but at pH 7.3 two of the
four helices bend and create a small pore at the His37/Trp41 region. The amantadine-bound
structure, solved with a 1.3 : 1 protein : amantadine molar ratio, shows a single drug molecule
in the pore, surrounded by residues that confer drug resistance (Fig. 5b). Thus, the amantadine
binding site and stoichiometry agree with electrophysiology data (16), and the crystal structure
supports a occlusion model for channel inhibition.
The solution NMR structure was solved on rimantadine-bound M2(18–60) in DHPC micelles
at pH 7.5 (PDB: 2RLF) (34). The sample contains 0.75 mM protein, 40 mM rimantadine and
300 mM DHPC, thus the drug is in 53-fold excess to the protein or ~210 fold excess to the
channel. The TM helix is tilted by ~15° from the bilayer normal and the C-terminal amphipathic
helix is roughly perpendicular to the TM helix. Low pH broadens the linewidths and increases
the millisecond motion of Trp41. Four protein-rimantadine NOEs were found to lipid-facing
residues L40, I42, L43, and R45 near the C-terminus of the TM helix, with four rimantadine
molecules per tetramer (Fig. 5c). Since this surface binding site is inconsistent with the large
body of mutagenesis data that place drug-resistant mutations at pore-facing residues at the N-
terminus, the authors proposed that rimantadine inhibits the channel by stabilizing its closed
state and making the channel harder to open, whereas drug-resistant mutations destabilize the
closed channel and make it easier to open. However, this allosteric inhibition model is
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inconsistent with the one-drug-per-channel stoichiometry of amantadine (16), and also
contradicts virus replication and whole cell conductance data that showed D44A and R45A
mutants to be amantadine sensitive (41). The drug – protein NOEs involve residues in the
headgroup region of the micelle, exactly where the amphiphilic rimantadine is located based
on paramagnetic relaxation NMR data (75,76). At the high concentration of 40 mM,
rimantadine constitutes 12 mol% of the micelle, making the surface binding site a likely
secondary lipid binding site rather than the true inhibition site. Given the abundant
reorientational dynamics of the peptide and amantadine discussed above (55,71), the lack of
NOEs between the N-terminal pore residues and rimantadine could arise from motion on
unfavorable time scales that broadens the NMR signals and/or makes the NOE intensity vanish,
or from micelle-altered helix orientation and packing that reject rimantadine in the pore. Thus,
while this work shows the presence of rimantadine on the surface of the protein, they do not
provide strong evidence against a pharmacologically relevant binding site in the pore.
It is unlikely for the different protein lengths to be the cause for the drug binding site difference,
since the TM peptide is capable of binding amantadine, folding into appropriate tetramers, and
having at least 50% of the proton conductance of full-length M2 (77).
The above two high-resolution structures were solved in detergents and micelles. Recently, an
amantadine-bound structure of M2(22–46) in DLPC bilayers was reported based on MAS
SSNMR data (36,55). The experiments were carried out at a peptide : amantadine : DLPC
molar ratio of 1 : 8 : 15. The main conformational constraints came from 13C and 15N isotropic
chemical shifts (CS) measured at 243 K where the protein dynamics is frozen. Comparison of
the apo and bound peptide chemical shifts indicated that the M2(22–46) conformation is most
perturbed by amantadine at S31, with a large 15N CS change of 7 ppm, strongly suggesting
drug binding near S31 (Fig. 6a). The CS perturbation is also high for G34 and V28, while the
C-terminal L38 and D44 are minimally affected (Fig. 6b). The chemical-shift predicted (φ,
ψ) angles for the apo and bound monomers also show that the apo peptide has a slightly larger
kink than the amantadine-bound peptide. The monomer structure was combined with the helix
orientation and inter-helical 19F-19F distances to lead to a tetramer structure for M2(22–46) at
pH 7.5 (PDB: 2KAD). The tetramer has larger N-terminus vestibule than the other structures,
and differs in the Trp41 conformation (36) (Fig. 5d). SSNMR studies also found that amantadine
slightly perturbs the sidechain conformations of V27 and V28 (78).
C. Future directions
While a large amount of biochemical and structural information have been obtained for the
M2 proton channel, many open questions remain about this fascinating multi-functional
protein. So far the most complete three-dimensional structures were solved in detergents and
micelles, which are only partial mimics of lipid bilayers. Given the plasticity of the protein,
high-resolution structural studies in lipid bilayers that mimic the virus envelope will be very
valuable. Most structural studies so far used partial constructs of the full-length protein, thus
future studies of the full-length protein will clearly be desirable, especially to understand the
role of the C-terminal amphipathic helix, which was found to be able to affect ion channel
function by interacting with the TM helix (79). Elucidating how M2 changes its conformation
and dynamics between high pH and low pH is central to understanding its activation, and will
require atomic-resolution information of His37 and Trp41 conformation as a function of pH.
Clearly, protein-drug distances in lipid bilayers will be essential for resolving the controversy
of M2 inhibition. Finally, the ultimate public health benefit of this research is to develop new
antiviral drugs to target the dominant mutants of influenza A viruses to prevent future influenza
pandemics. Achieving this end will require a combination of pharmacological, biochemical,
and structural studies.
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Fig. 1.
Amino acid sequence of influenza A/Udorn/72 M2 protein. The TM domain containing the
crucial His37 and Trp41 residues (red) are underlined.
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Fig. 2.
(a) Interhelical 19F-19F spin diffusion data of 5-19F-Trp41 WT M2 (red) and 4-19F-A30F M2
(black) in DMPC bilayers (59,67). The best-fit distances confirm the tetrameric state of the
peptide, and constrain the Trp41 sidechain (χ1, χ2) torsion angles (inset). (b) Trp41 t90 and
His37 t-160 rotamers proposed from the distance data.
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Fig. 3.
13C MAS spectra of DLPC-bound M2(22–46). (a) Variable temperature 13C MAS spectra
indicate large-amplitude intermediate timescale motion at ambient temperature (54). (b)
Amantadine narrows the linewidths of most residues at 313 K (55).
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Fig. 4.
Uniaxial diffusion of M2(22–46) helical bundles around the bilayer normal. (a) 15N CSA of
L26 is uniaxially averaged from the rigid-limit pattern (dashed line) (54). (b) L26 N–H dipolar
coupling is reduced from the rigid-limit coupling. (c) Amantadine decreases 1H T1ρ relaxation
rates at high temperature, indicating it speeds up protein motion (71). (d) Schematic of M2
uniaxial diffusion. Amantadine binding creates better packed tetramers, thus speeding up
rotational diffusion.
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Fig. 5.
High-resolution structures of the TM domain of AM2. (a) Amantadine-bound orientational
structure of M2(22–46) in DMPC bilayers at pH 8.8 from oriented-membrane SSNMR (PDB:
2H95) (48). The drug binding site was not directly studied but was implicitly assumed to be
in the pore at the N-terminus side. (b) Amantadine-bound crystal structure of M2(22–46) in
OG at pH 5.3 (PDB: 3C9J) (35). (c) Rimantadine-bound solution NMR structure of M2(18–
60) in DHPC micelles at pH 7.5 (PDB: 2RLF) (34). Only the TM part is shown. (d) Amantadine-
bound structure of M2(22–46) in DLPC bilayers at pH 7.5 from MAS SSNMR (PDB: 2KAD)
(36). The amantadine position is hypothesized based on chemical shift perturbation of S31.
The bilayer planes are drawn for reference. In each structure, two of the Trp41 indole rings
(green) are shown, and the drug molecules are shown in red. IN (c), only two rimantadine
molecules are shown for clarity.
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Fig. 6.
SSNMR evidence for amantadine binding near S31. (a) 2D 15N-13C correlation spectra of
DLPC-bound M2(22–46) in the absence (black) and presence (red) of amantadine (36). (b)
Chemical shift perturbation by amantadine in bilayer-bound M2(22–46).
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